Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: SVRA) | Delayed: 4.77 +0.01 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.76 | 52 Week High | $ | |||
| Open | $4.79 | 52 Week Low | $ | |||
| Day High | $4.95 | P/E | N/A | |||
| Day Low | $4.76 | EPS | $ | |||
| Volume | 1,286,023 | |||||
